Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Large-scale testing (Phase 3)UnknownNCT03909724
What this trial is testing

Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
Colorectal CancerMetastasis
Amsterdam UMC, location VUmc 60
Early research (Phase 1)Looking for participantsNCT07630961
What this trial is testing

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more
Novartis Pharmaceuticals 66
Early research (Phase 1)Looking for participantsNCT04150042
What this trial is testing

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Who this might be right for
Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more
General Oncology, Inc. 24
Not applicableLooking for participantsNCT05714124
What this trial is testing

Liver Embolization Approaches for Tumor Management

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaMetastatic Colon Cancer+4 more
IRCCS San Raffaele 580
Testing effectiveness (Phase 2)UnknownNCT01180153
What this trial is testing

Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)

Who this might be right for
Biliary Tract Cancer
Peking University Cancer Hospital & Institute 40
Not applicableLooking for participantsNCT00900419
What this trial is testing

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Who this might be right for
Esophageal CancerHead and Neck CancerLung Cancer+1 more
University of Colorado, Denver 700
Large-scale testing (Phase 3)UnknownNCT02891083
What this trial is testing

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Shanghai Chest Hospital 486
Testing effectiveness (Phase 2)UnknownNCT06206096
What this trial is testing

PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC

Who this might be right for
Colorectal CancerRAS MutationColorectal Neoplasms+1 more
Chinese PLA General Hospital 40
Early research (Phase 1)Study completedNCT04990037
What this trial is testing

The Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Cantargia AB 25
Early research (Phase 1)Study completedNCT06184841
What this trial is testing

HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma

Who this might be right for
Hepatic Arterial Infusion ChemotherapyLiver MetastasesEsophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 25
Not applicableStudy completedNCT07386639
What this trial is testing

Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerNeoplasm Metastasis
Tongji University 19,019
Early research (Phase 1)Study completedNCT02857270
What this trial is testing

LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more
Eli Lilly and Company 210
Early research (Phase 1)Looking for participantsNCT07197554
What this trial is testing

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more
SEED Therapeutics, Inc. 171
Testing effectiveness (Phase 2)Study completedNCT01608022
What this trial is testing

A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yonsei University 48
Not applicableUnknownNCT03881501
What this trial is testing

Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Huazhong University of Science and Technology 2
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03274011
What this trial is testing

Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasms
Fudan University 40
Testing effectiveness (Phase 2)Study completedNCT00273312
What this trial is testing

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Looking for participantsNCT07432295
What this trial is testing

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+3 more
I-Mab Biopharma US Limited 180
Next Page